Brennan Long

Brennan Long is a Partner and Research Analyst at Hood River Capital Management LLC, having joined the firm in 2018. Based in the United States, he specializes in biotechnology and healthcare investments, contributing over a decade of sector-specific experience to the team. At Hood River, Brennan is responsible for conducting deep research and generating investment ideas in the healthcare sector, with a particular focus on biotechnology companies.

His prior experience includes roles as an equity research associate at Bloomberg Intelligence, where he covered biotechnology, and at Janney Montgomery Scott, focusing on specialty pharmaceuticals. Earlier in his career, he worked as a healthcare analyst at Major Assets Management and held a business development position at Novartis, further solidifying his credentials in the life sciences and pharmaceutical industries.

Brennan holds a B.A. in architectural studies from Middlebury College and an M.A. in biotechnology from Columbia University, highlighting his strong analytical background and technical expertise in healthcare. Throughout his career, he has built a reputation for in-depth fundamental research and insights into the biotechnology and pharmaceutical sectors, supporting Hood River’s small-cap and mid-cap growth strategies.